Fluarix/Influsplit Tetra
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluarix/Influsplit Tetra, covering 2015-01-12 to 2015-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older [Phase 3]